CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017
Operating Activities
Net loss	$ (7,925)	$ (11,439)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	11,789	13,259
Stock-based compensation expense	750	858
Loss on impairment of long-lived assets	2,236	3,267
Loss on disposal of assets	238	283
Grow NJ award benefit	(1,977)	1,096
Amortization of deferred financing costs	506	375
Decrease (increase) in:
Trade receivables	(569)	(1,218)
Inventories	(7,798)	(4,896)
Prepaid expenses and other current assets	1,251	3,110
Other non-current assets	35	(59)
(Decrease) increase in:
Accounts payable, accrued expenses and other current liabilities	(3,861)	2,474
Deferred rent and other non-current liabilities	(2,087)	23
Net cash provided by (used in) operating activities	(7,412)	7,133
Investing Activities
Capital expenditures	(3,456)	(5,484)
Additions to intangible assets		(18)
Net cash used in investing activities	(3,456)	(5,502)
Financing Activities
Decrease in cash overdraft	(1,486)	(461)
Increase in line of credit borrowings	13,700	3,600
Proceeds from long-term debt	2,500	3,401
Repayment of long-term debt	(3,935)	(8,493)
Deferred financing costs paid	(160)	(277)
Withholding taxes on stock-based compensation paid in connection with repurchase of common stock	(136)	(45)
Proceeds from exercise of stock options	1
Net cash provided by (used in) financing activities	10,484	(2,275)
Effect of exchange rate changes on cash and cash equivalents	(4)	2
Net Decrease in Cash and Cash Equivalents	(388)	(642)
Cash and Cash Equivalents, Beginning of Period	1,635	2,859
Cash and Cash Equivalents, End of Period	1,247	2,217
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	2,997	2,640
Cash (received) paid for income taxes	$ 118	$ (4,240)